Neo Ivy Capital Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1,202
-95.5%
29,634
+3540.5%
0.81%
+1045.1%
Q3 2022$27,000
+107.7%
814
+313.2%
0.07%
+273.7%
Q4 2021$13,000
+116.7%
197
+173.6%
0.02%
+216.7%
Q2 2021$6,000
-62.5%
72
-80.7%
0.01%
-62.5%
Q3 2020$16,000
+433.3%
373
+191.4%
0.02%
+1500.0%
Q2 2020$3,000
-78.6%
128
-41.3%
0.00%
-93.8%
Q4 2019$14,000
+366.7%
218
+70.3%
0.02%
+700.0%
Q2 2019$3,0001280.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders